Screener
Chemours CC R&D
R&D at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Chemours in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Chemours’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 11:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001627223-26-000024
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of goods sold | 1,305 | 1,337 | 2,474 | 2,469 |
| Gross profit | 286 | 278 | 498 | 514 |
| Selling, general, and administrative expense | 469 | 424 | 616 | 547 |
| Research and development expense | 27 | 28 | 53 | 55 |
| Restructuring, asset-related, and other charges | 3 | 18 | 16 | 51 |
| Total other operating expenses | 499 | 470 | 685 | 653 |
| Equity in earnings of affiliates | 9 | 9 | 17 | 17 |
| Interest expense, net | (68) | (67) | (137) | (133) |
Item 1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Chemours's R&D?
- Chemours (CC) reported R&D of $27M in Q2 2026.
- How has Chemours's R&D changed year-over-year?
- Chemours's R&D decreased by 3.6% year-over-year, from $28M to $27M.
- What is the long-term trend for Chemours's R&D?
- Over 4 years (2021 to 2025), Chemours's R&D has grown at a 0.2% compound annual growth rate (CAGR), from $107M to $108M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Chemours's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude